Fanglei You

423 total citations
9 papers, 302 citations indexed

About

Fanglei You is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Fanglei You has authored 9 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Fanglei You's work include Immunotherapy and Immune Responses (3 papers), HER2/EGFR in Cancer Research (2 papers) and Dermatologic Treatments and Research (2 papers). Fanglei You is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), HER2/EGFR in Cancer Research (2 papers) and Dermatologic Treatments and Research (2 papers). Fanglei You collaborates with scholars based in United States, Israel and United Kingdom. Fanglei You's co-authors include Lyndsay N. Harris, Paula N. Friedman, J. Dirk Iglehart, Harold J. Burstein, Dennis C. Sgroi, Steven E. Come, Paula D. Ryan, Rebecca Gelman, Eric P. Winer and Agnes Witkiewicz and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Fanglei You

9 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fanglei You United States	6	197	114	94	88	32	9	302
Andrée Rorive Belgium	12	197 1.0×	114 1.0×	83 0.9×	34 0.4×	107 3.3×	49	344
Shih‐Che Shen Taiwan	9	139 0.7×	105 0.9×	28 0.3×	102 1.2×	43 1.3×	21	303
Sheila J. Dearing United Kingdom	5	260 1.3×	169 1.5×	43 0.5×	112 1.3×	61 1.9×	7	367
Sufeng Mao United States	4	216 1.1×	159 1.4×	25 0.3×	233 2.6×	21 0.7×	5	408
Mai Tomiguchi Japan	12	146 0.7×	280 2.5×	37 0.4×	272 3.1×	80 2.5×	24	490
Johanne Lade‐Keller Denmark	8	193 1.0×	169 1.5×	12 0.1×	45 0.5×	38 1.2×	17	304
John Hunts Japan	7	229 1.2×	246 2.2×	89 0.9×	43 0.5×	89 2.8×	7	411
Santino Minichillo Italy	9	160 0.8×	84 0.7×	35 0.4×	137 1.6×	120 3.8×	17	347
Nobuhiro Imanaka Japan	6	162 0.8×	180 1.6×	38 0.4×	193 2.2×	24 0.8×	11	359
Erick Romàn-Pèrez United States	5	177 0.9×	173 1.5×	20 0.2×	164 1.9×	32 1.0×	6	343

Countries citing papers authored by Fanglei You

Since Specialization

Citations

This map shows the geographic impact of Fanglei You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanglei You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanglei You more than expected).

Fields of papers citing papers by Fanglei You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanglei You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanglei You. The network helps show where Fanglei You may publish in the future.

Co-authorship network of co-authors of Fanglei You

This figure shows the co-authorship network connecting the top 25 collaborators of Fanglei You. A scholar is included among the top collaborators of Fanglei You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanglei You. Fanglei You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hurov, Kristen E., Johanna Lahdenranta, Punit Upadhyaya, et al.. (2021). BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism. Journal for ImmunoTherapy of Cancer. 9(11). e002883–e002883. 25 indexed citations

Hurov, Kristen E., Johanna Lahdenranta, Punit Upadhyaya, et al.. (2021). Abstract 1728: Nectin-4-dependent immune cell stimulation and anti-tumor efficacy by BT7480, a Nectin-4/CD137 Bicycle®tumor-targeted immune cell agonist (TICA™). Cancer Research. 81(13_Supplement). 1728–1728. 1 indexed citations

Upadhyaya, Punit, Kristen E. Hurov, Jun Ma, et al.. (2020). 706 BT7480, a fully synthetic tumor-targeted immune cell agonist (TICA™) induces tumor localized CD137 agonism and modulation of tumor immune microenvironment. Regular and Young Investigator Award Abstracts. A424.1–A424. 2 indexed citations

Tibayan, Frederick A., Samantha Louey, Sonnet S. Jonker, et al.. (2015). Increased systolic load causes adverse remodeling of fetal aortic and mitral valves. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 309(12). R1490–R1498. 1 indexed citations

Wong, Victor W., Fanglei You, Michael Januszyk, Geoffrey C. Gurtner, & Anna A. Kuang. (2014). Transcriptional Profiling of Rapamycin-Treated Fibroblasts From Hypertrophic and Keloid Scars. Annals of Plastic Surgery. 72(6). 711–719. 33 indexed citations

Wong, Victor W., Fanglei You, Michael Januszyk, & Anna A. Kuang. (2013). Tacrolimus fails to regulate collagen expression in dermal fibroblasts. Journal of Surgical Research. 184(1). 678–690. 8 indexed citations

You, Fanglei, Lisa Roberts, Soonmo Peter Kang, et al.. (2008). Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells. Journal of Hematology & Oncology. 1(1). 2–2. 28 indexed citations

Harris, Lyndsay N., Fanglei You, Stuart J. Schnitt, et al.. (2007). Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer. Clinical Cancer Research. 13(4). 1198–1207. 190 indexed citations

You, Fanglei, Natsuko Chiba, Chikashi Ishioka, & Jeffrey D. Parvin. (2004). Expression of an amino-terminal BRCA1 deletion mutant causes a dominant growth inhibition in MCF10A cells. Oncogene. 23(34). 5792–5798. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact